Objective: Epidemiologic surveys have found that the incidence and pre
valence of panic disorder decline in later life. The goal of this stud
y was to determine whether aging has an effect on healthy subjects' re
sponses to the panicogenic agent cholecystokinin tetrapeptide (CCK-4).
Method: The study used a double-blind, placebo-controlled design: 40
subjects 20-35 years old and 40 subjects 65 years old or older were ra
ndomly assigned to receive an intravenous bolus of either 50 mu g of C
CK-4 or normal saline. Results: When given CCK-4, older subjects had s
ignificantly fewer and less intense symptoms of panic, shorter duratio
n of symptoms, and less of an increase in heart rate than did younger
subjects. Conclusions: This study found art age-related change in resp
onsiveness to CCK-4. Further research to delineate the mechanism of th
is change is warranted.